Identification and multimodal characterization of a specialized epithelial cell type associated with Crohn’s disease
Jia Li(Zhejiang Chinese Medical University), Qi Liu(Vanderbilt University Medical Center), Sara Horst(Vanderbilt University Medical Center), Sophie Chiron(Vanderbilt University), Frank Revetta(Vanderbilt University Medical Center), Alain P. Gobert(Vanderbilt University), Larry Raber(Vanderbilt University Medical Center), Yash A. Choksi(VA Tennessee Valley Healthcare System), Justin Jacobse(Leiden University Medical Center), Marisol Ramirez‐Solano(Vanderbilt University Medical Center), Margaret M. Allaman(Vanderbilt University Medical Center), Jennifer M. Pilat(Vanderbilt University), Jeremy A. Goettel(Vanderbilt University Medical Center), Keith T. Wilson(VA Tennessee Valley Healthcare System), Harsimran Kaur(Vanderbilt University), Joseph T. Roland(Vanderbilt University Medical Center), Caroline V. Hawkins(Vanderbilt University Medical Center), Elizabeth Scoville(Vanderbilt University), Shunxing Bao(Vanderbilt University), Kara M. McNamara(Vanderbilt University), Robin Dalal(Vanderbilt University Medical Center), Ken S. Lau(Vanderbilt University), Dawn B. Beaulieu(Vanderbilt University Medical Center), Yu Shyr(Vanderbilt University), Yanwen Xu(Guangzhou Women and Children Medical Center), Yuankai Huo(Vanderbilt University), Lori A. Coburn(VA Tennessee Valley Healthcare System), Bennett A. Landman(Vanderbilt University), Regina N. Tyree(Vanderbilt University Medical Center), M. Kay Washington(Vanderbilt University Medical Center), Gabriella Raffa(Vanderbilt University Medical Center), Paige N. Vega(Vanderbilt University), Naila Tasneem(Vanderbilt University), Mohammad Asim(University of Cambridge), Alan J. Simmons(Vanderbilt University), Can Cui(Vanderbilt University), Baldeep Pabla(Vanderbilt University Medical Center), Anna N. Conner(Vanderbilt University Medical Center), David A. Schwartz(St. Jude Children's Research Hospital)
Cited by 52
Related Papers
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis
|Cancer Cell|2004|1.1k
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy
|Nature Communications|2016|580
DC isoketal-modified proteins activate T cells and promote hypertension
|Journal of Clinical Investigation|2014|533